KORU Medical Systems (NASDAQ:KRMD – Get Free Report) and Health Catalyst (NASDAQ:HCAT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.
Profitability
This table compares KORU Medical Systems and Health Catalyst’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| KORU Medical Systems | -9.49% | -22.43% | -13.86% |
| Health Catalyst | -34.05% | -6.67% | -3.21% |
Risk and Volatility
KORU Medical Systems has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| KORU Medical Systems | 1 | 1 | 3 | 1 | 2.67 |
| Health Catalyst | 1 | 8 | 5 | 0 | 2.29 |
KORU Medical Systems currently has a consensus target price of $6.13, suggesting a potential upside of 13.64%. Health Catalyst has a consensus target price of $4.32, suggesting a potential upside of 100.85%. Given Health Catalyst’s higher possible upside, analysts plainly believe Health Catalyst is more favorable than KORU Medical Systems.
Valuation and Earnings
This table compares KORU Medical Systems and Health Catalyst”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| KORU Medical Systems | $33.65 million | 7.42 | -$6.07 million | ($0.08) | -67.38 |
| Health Catalyst | $306.58 million | 0.50 | -$69.50 million | ($1.59) | -1.35 |
KORU Medical Systems has higher earnings, but lower revenue than Health Catalyst. KORU Medical Systems is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 20.6% of KORU Medical Systems shares are held by company insiders. Comparatively, 2.6% of Health Catalyst shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
Health Catalyst beats KORU Medical Systems on 8 of the 15 factors compared between the two stocks.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
About Health Catalyst
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
